Pub. Date : 2021 Jun 24
PMID : 34202639
3 Functional Relationships(s)Download |
Sentence | Compound Name | Protein Name | Organism |
1 | The bulky pentalenofurane skeleton is expected to introduce more hindrance in the prostaglandin analogues of type III, greater than that obtained with the bicyclo(3.3.0)oct(a)ene fragments of prostaglandin analogues I and II, to slow down (retard) the inactivation of the prostaglandin analogues by oxidation of 15alpha-OH to the 15-keto group via the 15-PGDH pathway. | Prostaglandins | 15-hydroxyprostaglandin dehydrogenase | Homo sapiens |
2 | The bulky pentalenofurane skeleton is expected to introduce more hindrance in the prostaglandin analogues of type III, greater than that obtained with the bicyclo(3.3.0)oct(a)ene fragments of prostaglandin analogues I and II, to slow down (retard) the inactivation of the prostaglandin analogues by oxidation of 15alpha-OH to the 15-keto group via the 15-PGDH pathway. | Prostaglandins | 15-hydroxyprostaglandin dehydrogenase | Homo sapiens |
3 | The bulky pentalenofurane skeleton is expected to introduce more hindrance in the prostaglandin analogues of type III, greater than that obtained with the bicyclo(3.3.0)oct(a)ene fragments of prostaglandin analogues I and II, to slow down (retard) the inactivation of the prostaglandin analogues by oxidation of 15alpha-OH to the 15-keto group via the 15-PGDH pathway. | Prostaglandins | 15-hydroxyprostaglandin dehydrogenase | Homo sapiens |